Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Mutation Research|October 12, 2000
Immunohistochemical expression of p53 in breast carcinoma is associated with the intron 1 BglII polymorphism of the p53 geneC Trejo-Becerril, R G Sarmiento, M M Abad, et al.Medical Oncology (Northwood, London, England)|November 11, 2009
Pharmacogenetics and pharmacoepigenetics of gemcitabineM Candelaria, E de la Cruz-Hernández, E Pérez-Cárdenas, et al.Journal of Experimental & Clinical Cancer Research : CR|June 20, 2002
Correlation of tumor growth index with early treatment response in cervical carcinomaC Trejo-Becerril, L Rivera, J Chanona, et al.Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Membrane proteins in neoplasic and normal uterine cervixC Trejo-Becerril, E Pérez-Cárdenas, L Taja-Chayeb, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2002
Neuroendocrine marker expression in cervical carcinomas of non-small cell typeA Chavez-Blanco, L Taja-Chayeb, L Cetina, et al.Clinics and Research in Hepatology and Gastroenterology|October 17, 2021
Hereditary diffuse gastric cancer (HDGC). An overviewL Taja-Chayeb, S Vidal-Millán, C Trejo-Becerril, et al.European Journal of Gynaecological Oncology|October 2, 2010
Epigenetic therapy and cisplatin chemoradiation in FIGO stage IIIB cervical cancerM Candelaria, L Cetina, E Pérez-Cárdenas, et al.International Journal of Clinical Pharmacology and Therapeutics|July 26, 2011
Pharmacokinetics of hydralazine, an antihypertensive and DNA-demethylating agent, using controlled-release formulations designed for use in dosing schedules based on the acetylator phenotypeA Gonzalez-Fierro, D Vasquez-Bahena, L Taja-Chayeb, et al.International Journal of Oncology|August 2, 2011
Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproateA Chávez-Blanco, E De la Cruz-Hernández, G I Domínguez, et al.Immunology Letters|June 16, 1999
Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV-18 infectionA M García, V F Ortíz-Navarrete, M L Mora-García, et al.Pageof 2